Insider Transactions in Q3 2022 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2022
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
2,545
-2.27%
|
$2,545
$1.2 P/Share
|
|
Sep 02
2022
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
2,308
-2.43%
|
$2,308
$1.2 P/Share
|
|
Sep 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
172
-4.47%
|
$172
$1.2 P/Share
|
|
Sep 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
1,444
-7.5%
|
$1,444
$1.2 P/Share
|
|
Sep 02
2022
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
2,234
-0.77%
|
$2,234
$1.2 P/Share
|
|
Sep 02
2022
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
2,234
-2.2%
|
$2,234
$1.2 P/Share
|
|
Sep 01
2022
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,063
+4.32%
|
-
|
|
Sep 01
2022
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,063
+5.05%
|
-
|
|
Sep 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
508
+11.67%
|
-
|
|
Sep 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,896
+13.07%
|
-
|
|
Sep 01
2022
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,063
+1.71%
|
-
|
|
Sep 01
2022
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,063
+4.76%
|
-
|
|
Aug 02
2022
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
4,654
-2.39%
|
$4,654
$1.46 P/Share
|
|
Aug 02
2022
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
4,330
-2.0%
|
$4,330
$1.46 P/Share
|
|
Aug 02
2022
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
3,802
-0.66%
|
$3,802
$1.46 P/Share
|
|
Aug 02
2022
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
4,807
-2.64%
|
$4,807
$1.46 P/Share
|
|
Aug 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
77
-2.25%
|
$77
$1.46 P/Share
|
|
Aug 02
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
1,732
-5.15%
|
$1,732
$1.46 P/Share
|
|
Aug 01
2022
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,249
+5.0%
|
-
|
|
Aug 01
2022
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+3.72%
|
-
|
|
Aug 01
2022
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+1.44%
|
-
|
|
Aug 01
2022
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,249
+5.32%
|
-
|
|
Aug 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
181
+5.03%
|
-
|
|
Aug 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,376
+9.12%
|
-
|
|
Jul 05
2022
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
7
-0.22%
|
$14
$2.71 P/Share
|
|
Jul 01
2022
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
16
+0.49%
|
-
|